SCHEMBL17358232

SCHEMBL17358232

Cc1cc(OCc2ccccc2)c2c(c1)O[C@H](c1ccc(OCc3ccccc3)c(OCc3ccccc3)c1)[C@@H](OCc1ccccc1)[C@H]2O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 2/20 0.37
▸ CETP P11597 1/20 0.36
▸ PDE4A P27815 1/20 0.36
▸ PDE4B Q07343 1/20 0.36
▸ PDE4C Q08493 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ C5AR1 P21730 1/20 0.35
▸ MAPT P10636 3/20 0.34
▸ TDP1 Q9NUW8 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ AKR1B1 P15121 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.34
▸ EGFR P00533 2/20 0.34
▸ MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17358248 0.93 FFAR4 (0.40) CETPMAPTTDP1L3MBTL1CYP2C9
SCHEMBL18427307 0.88 PIN1 (0.38) APPPDE4APDE4BPDE4CPDE4D
SCHEMBL5268318 0.88 PIN1 (0.38) APPPDE4APDE4BPDE4CPDE4D
SCHEMBL5265501 0.88 PIN1 (0.38) APPPDE4APDE4BPDE4CPDE4D
SCHEMBL5620552 0.80 SIRT1 (0.41) MAPTL3MBTL1CYP2C19HIF1AMAOB
SCHEMBL17523255 0.80 MRGPRX4 (0.43) —
SCHEMBL5523109 0.80 SIRT1 (0.41) MAPTL3MBTL1CYP2C19HIF1AMAOB
SCHEMBL3932082 0.78 STING1 (0.41) APPPDE4APDE4BPDE4CPDE4D
SCHEMBL15450266 0.78 CYP3A4 (0.44) APPPDE4APDE4BPDE4CPDE4D
SCHEMBL15450257 0.78 CYP3A4 (0.44) APPPDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9556140-B2 Approach for synthesis of catechins SPHAERA PHARMA PVT. LTD. (IN) 2017-01-31 — — US disclosed
US-20150368223-A1 NOVEL APPROACH FOR SYNTHESIS OF CATECHINS EPIRIUM BIO INC. 2015-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150368223-A1 NOVEL APPROACH FOR SYNTHESIS OF CATECHINS NQO1, COMT, NNMT APP 3048/4885CETP 928/4885PDE4A 3768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback